ArticleDiabetes spectrum : a publication of the American Diabetes Association2021

Exploring Why People With Type 2 Diabetes Do or Do Not Persist With Glucagon-Like Peptide-1 Receptor Agonist Therapy: A Qualitative Study.

William Polonsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.